Research and Articles

NDA-Hotline

M&A Hotline

1234

TITLE 

DATE 

Musk Pops Twitter’s Poison Pill Without Any Side Effects!

04-28-2022

SEBI Cracks Down on Unsolicited Trading Tips!

04-14-2022

Non-compete clauses: protection or restraint?

12-22-2020

Cracking the Anti-Dilution Formula

07-01-2020

Ghosts of the past: Another shot in the arm for acquisition under IBC

05-08-2020

100% FDI PERMITTED IN INSURANCE INTERMEDIARIES

04-29-2020

Can COVID-19 amount to a Material Adverse Change?

04-01-2020

The Way Forward – Indian M&A and PE Projections for 2019

01-25-2019

SEBI eases delisting norms – Major impetus for take-private transactions

11-24-2018

SEBI corporate governance norms: will change be the promising constant?

04-17-2018

PE Investment in Insurance Companies: Relaxation or Restriction?

02-05-2018

SEBI on cleaning spree – issues clarifications on takeover exemptions, schemes of arrangements

01-11-2018

Interpretation of ‘control’: An uncontrolled increase in ambiguity?

05-04-2017

Provision enabling cross-border mergers notified: India further integrates into the stream of globalization

04-21-2017

Revamping the scheme of arrangement/amalgamation requirements for listed entities – SEBI overhauls the regulatory framework!

04-05-2017

Evaluation of the Board of Directors of the Listed Company: The Need of the Hour?

01-24-2017

Time to reconsider mergers and acquisitions pricing norms?

07-21-2016

Change in Merger Control Thresholds

03-08-2016

IRDAI: Walking the talk?

12-24-2015

'Going Private' Transactions: Set for a Boost?

04-22-2015